Intensive Monitoring Scheme of Lidocaine Cataplasms
NCT05645302
·
clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Adverse Reaction to Drug
Interventions
DRUG:
Lidocaine Cataplasms
Sponsor
Qianfoshan Hospital